Rivastigmine is a cholinesterase inhibitor which improves cognitive function and is currently being used in patients with mild to moderate Parkinson's and Alzheimer's dementia. This drug can be given orally or topically, as transdermal patch. The latter form is currently used for most excellent compliance and few side effects. The most common cutaneous side effects are irritative dermatitis. We report the second case of active sensitization by the rivastigmine-patch in a patient suffering from Alzheimer's dementia.
An atypical cutaneous reaction to rivastigmine transdermal patch / T. Grieco, M. Rossi, V. Faina, I. De Marco, P. Pigatto, S. Calvieri. - In: JOURNAL OF ALLERGY. - ISSN 1687-9783. - 2011:(2011 Jan), pp. 752098.1-752098.2. [10.1155/2011/752098]
An atypical cutaneous reaction to rivastigmine transdermal patch
P. PigattoPenultimo
;
2011
Abstract
Rivastigmine is a cholinesterase inhibitor which improves cognitive function and is currently being used in patients with mild to moderate Parkinson's and Alzheimer's dementia. This drug can be given orally or topically, as transdermal patch. The latter form is currently used for most excellent compliance and few side effects. The most common cutaneous side effects are irritative dermatitis. We report the second case of active sensitization by the rivastigmine-patch in a patient suffering from Alzheimer's dementia.
| File | Dimensione | Formato | |
|---|---|---|---|
|
JA2011-752098.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
583.09 kB
Formato
Adobe PDF
|
583.09 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
